- Home
- PMEC vs PYPD Comparison
PMEC vs PYPD Comparison
Compare PMEC & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- PYPD
- Stock Information
- Founded
- PMEC 1984
- PYPD 2008
- Country
- PMEC Singapore
- PYPD Israel
- Employees
- PMEC N/A
- PYPD N/A
- Industry
- PMEC
- PYPD Medical/Dental Instruments
- Sector
- PMEC
- PYPD Health Care
- Exchange
- PMEC Nasdaq
- PYPD Nasdaq
- Market Cap
- PMEC 29.3M
- PYPD 24.1M
- IPO Year
- PMEC 2023
- PYPD 2020
- Fundamental
- Price
- PMEC $0.76
- PYPD $3.40
- Analyst Decision
- PMEC
- PYPD Strong Buy
- Analyst Count
- PMEC 0
- PYPD 2
- Target Price
- PMEC N/A
- PYPD $12.00
- AVG Volume (30 Days)
- PMEC 57.5K
- PYPD 7.6K
- Earning Date
- PMEC 12-26-2024
- PYPD 11-13-2024
- Dividend Yield
- PMEC N/A
- PYPD N/A
- EPS Growth
- PMEC N/A
- PYPD N/A
- EPS
- PMEC N/A
- PYPD N/A
- Revenue
- PMEC $72,524,000.00
- PYPD N/A
- Revenue This Year
- PMEC N/A
- PYPD N/A
- Revenue Next Year
- PMEC N/A
- PYPD N/A
- P/E Ratio
- PMEC N/A
- PYPD N/A
- Revenue Growth
- PMEC 5.07
- PYPD N/A
- 52 Week Low
- PMEC $0.49
- PYPD $2.95
- 52 Week High
- PMEC $4.15
- PYPD $9.20
- Technical
- Relative Strength Index (RSI)
- PMEC 50.46
- PYPD 48.44
- Support Level
- PMEC $0.67
- PYPD $3.33
- Resistance Level
- PMEC $0.78
- PYPD $3.58
- Average True Range (ATR)
- PMEC 0.06
- PYPD 0.25
- MACD
- PMEC -0.00
- PYPD 0.01
- Stochastic Oscillator
- PMEC 52.14
- PYPD 38.46
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.